ecancermedicalscience

Review

Conducting Phase IV clinical studies: a moral imperative?

26 Oct 2012
TP Hill

The answer to this question lies in knowing the moral standing of Phase IV studies and whether we ought to conduct them. And to know this, in part, we need to compare them to studies in Phases I, II, and III and then determine where Phase IV studies stand in relation to Phase I–III studies scientifically and commercially.

Related Articles

Matías A Atencio, Elías J Ortega Chahla, Mirko Vidic, Candela V Giuffré, Mickaela Echavarría Demichelis, Joaquín A Luini, Franco E Espinoza, Ana M Rosas, María Cruz Germain, Abril Montani, Iñaki M Dopazo Danieli, Joel A Schernenco, Lucas G Durán, María E Esandi
Ravikant Singh, Atul Budukh Suvarna Kolekar, Gaurav Kumar, Burhanuddin Qayyumi, Tulika Gupta, Zikki Hassan Fatima, Narpat Padvi, Samyukta Shivashankar, Alisha Shah, Deepak Gupta, Nishant Kumar, Kumar Prabhash
M T Maria Tereza Nieto-Coronel, Daniela Shveid Gerson, Gian Karla Urey Cuellar, Navia-Bueno Ma Pilar, Maribel Marmol Casas
Patricia N Apenteng, Larry Akoko, Vihar Kotecha, Theresia Mwakyembe, Masumbuko Mwashambwa, Rukia Himid, Deo Hando, Charles Komba, Ally Mwanga, Peter Mbele, Paul Itule, Joshua Jackson, Mungeni Misidai, Cameron Gaskill, Doruk Ozgediz, Nathan Brand
Moushumi Suryavanshi, Prashant Mehta, Manoj Kumar, Saphalta Bhagmar, Vidit Kapoor, Dushyant Kumar, Sweta Mishra, Bhawna Chauhan